Biblioteca Humberto Rosselli Quijano
Información del autor
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
[artículo]
| Título : |
Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex : relation to antipsychotic induced hyperprolactinemia |
| Tipo de documento: |
texto impreso |
| Autores: |
Ryosuke Arakawa, Autor ; Masaki Okumura, Autor ; Hiroshi Ito, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 1131-1137 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antipsicóticos, Benzodiacepinas, Corteza cerebelosa, Corteza cerebral, Haloperidol, Hiperprolactinemia, Glándula pituitaria, Risperidona, Esquizofrenia. |
| Resumen: |
Hyperprolactinemia is a common side effect of antipsychotic drugs used in the treatment of schizophrenia. However, the magnitude of hyperprolactinemia differs among antipsychotics, and there is no reliable mechanism-related marker for the risk of hyperprolactinemia that would allow us to characterize antipsychotics. |
| Link: |
./index.php?lvl=notice_display&id=28222 |
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 9 (Septiembre) . - pp. 1131-1137
[artículo] Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex : relation to antipsychotic induced hyperprolactinemia [texto impreso] / Ryosuke Arakawa, Autor ; Masaki Okumura, Autor ; Hiroshi Ito, Autor . - 2022 . - pp. 1131-1137. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 9 (Septiembre) . - pp. 1131-1137
| Palabras clave: |
Antipsicóticos, Benzodiacepinas, Corteza cerebelosa, Corteza cerebral, Haloperidol, Hiperprolactinemia, Glándula pituitaria, Risperidona, Esquizofrenia. |
| Resumen: |
Hyperprolactinemia is a common side effect of antipsychotic drugs used in the treatment of schizophrenia. However, the magnitude of hyperprolactinemia differs among antipsychotics, and there is no reliable mechanism-related marker for the risk of hyperprolactinemia that would allow us to characterize antipsychotics. |
| Link: |
./index.php?lvl=notice_display&id=28222 |
|
